{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "messageBoardId": "finmb_702706441", "regularMarketChangePercent": -0.9618099, "regularMarketPrice": 0.3501, "exchange": "NCM", "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1631712600000, "priceHint": 4, "regularMarketChange": -0.003399998, "regularMarketTime": 1684180576, "regularMarketDayHigh": 0.36, "regularMarketDayRange": "0.3501 - 0.36", "regularMarketDayLow": 0.3501, "regularMarketVolume": 2032, "regularMarketPreviousClose": 0.3535, "bid": 0.0, "ask": 0.0, "bidSize": 13, "askSize": 13, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 0.36, "averageDailyVolume3Month": 54068, "averageDailyVolume10Day": 41520, "fiftyTwoWeekLowChange": 0.04010001, "fiftyTwoWeekLowChangePercent": 0.12935486, "fiftyTwoWeekRange": "0.31 - 1.54", "fiftyTwoWeekHighChange": -1.1898999, "fiftyTwoWeekHighChangePercent": -0.7726623, "fiftyTwoWeekLow": 0.31, "fiftyTwoWeekHigh": 1.54, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.54, "epsForward": -0.71, "epsCurrentYear": -0.55, "priceEpsCurrentYear": -0.6365455, "sharesOutstanding": 29248700, "bookValue": 1.632, "fiftyDayAverage": 0.40376, "fiftyDayAverageChange": -0.053659976, "fiftyDayAverageChangePercent": -0.13290067, "twoHundredDayAverage": 0.82001, "twoHundredDayAverageChange": -0.46991, "twoHundredDayAverageChangePercent": -0.57305396, "marketCap": 10239970, "forwardPE": -0.49309862, "priceToBook": 0.21452206, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Pasithea Therapeutics", "symbol": "KTTA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "702 514 4174", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for Central Nervous System disorders, RASopathies, and other diseases. It operates through two segments, Therapeutics and Clinics. The company provides business support services to anti-depression clinics, entities, and registered healthcare providers. Its lead product candidate PAS-004, a next-generation mitogen-activated protein kinase, or MEK inhibitor designed to be macrocyclic for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 and Noonan syndrome, as well as lamin A/C cardiomyopathy and oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; PAS-002, for the treatment multiple sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 74, "title": "Exec. Chairman & Co-Founder", "yearBorn": 1948, "fiscalYear": 2022, "totalPay": {"raw": 250000, "fmt": "250k", "longFmt": "250,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 44, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 539250, "fmt": "539.25k", "longFmt": "539,250"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 327910, "fmt": "327.91k", "longFmt": "327,910"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yassine  Bendiabdallah Ph.D.", "age": 36, "title": "COO & Head of UK Clinics", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Graeme  Currie Ph.D.", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}